About Zeiss

ZEISS is an internationally leading technology enterprise operating in the fields of optics and optoelectronics. In the previous fiscal year, the ZEISS Group generated annual revenue totaling more than 6.4 billion euros in its four segments Semiconductor Manufacturing Technology, Industrial Quality & Research, Medical Technology and Consumer Markets (status: 30 September 2019).

For its customers, ZEISS develops, produces and distributes highly innovative solutions for industrial metrology and quality assurance, microscopy solutions for the life sciences and materials research, and medical technology solutions for diagnostics and treatment in ophthalmology and microsurgery. The name ZEISS is also synonymous with the world’s leading lithography optics, which are used by the chip industry to manufacture semiconductor components. There is global demand for trendsetting ZEISS brand products such as eyeglass lenses, camera lenses and binoculars.

With a portfolio aligned with future growth areas like digitalization, healthcare and Smart Production and a strong brand, ZEISS is shaping the future of technology and constantly advancing the world of optics and related fields with its solutions. The company’s significant, sustainable investments in research and development lay the foundation for the success and continued expansion of ZEISS’ technology and market leadership.

With over 31,000 employees, ZEISS is active globally in almost 50 countries with around 60 sales and service companies, 30 production sites and 25 development sites. Founded in 1846 in Jena, the company is headquartered in Oberkochen, Germany. The Carl Zeiss Foundation, one of the largest foundations in Germany committed to the promotion of science, is the sole owner of the holding company, Carl Zeiss AG.

Contact

Carl-Zeiss-Straße 22
73447 Oberkochen
Germany

info.de@zeiss.com
+49 7364 20-0

https://www.zeiss.com/

Toepassingen

Aanvullen

Technologieën

Aanvullen

Thema’s

Aanvullen

Gepubliceerde artikelen

Koningin Máxima opent supercomputer voor Nederlandse wetenschap

Koningin Maxima 'opent' supercomputer (credits: Vera…
23 september 2021/door Aurélie Veltema

Video case VIRAPOC, de toekomst in virusdiagnostiek

Het VIRAPOC-project betreft de ontwikkeling van een lab-on-a-chip…
21 september 2021/door Aurélie Veltema

Matchmaking NWA safety assessment via animal-free models

Met dit online matchmaking platform brengen we verschillende…
14 september 2021/door Aurélie Veltema

NWO Spinoza premie voor Lieven Vandersypen

Professor Lieven Vandersypen (Foto: Studio Oostrum)

NWO heeft…
10 september 2021/door Aurélie Veltema

De international MicroNanoConference 2021 is geannuleerd

De international MicroNanoConference is de conferentie van MinacNed…
9 september 2021/door Aurélie Veltema

Nieuwe NWO subsidie instrumenten beschikbaar

Vergrijzing, diabetes type 2, tekort aan zorgpersoneel; onze…
8 september 2021/door Aurélie Veltema

Nikon opent eerste Europese Nikon BioImaging Lab op Leiden Bio Science Park

Amsterdam, Nederland, 24 Augustus 2021 – Nikon Europe B.V. heeft…
24 augustus 2021/door Aurélie Veltema

IamFluidics: Nieuwe ontwikkelingen in farmaceutisch onderzoek

Het ontwikkelen van hoogwaardige microdeeltjes om disruptieve…
24 augustus 2021/door Aurélie Veltema

Join the iMNC21 business floor for networking and a company pitch

Nu iedereen weer terugkeert van zomervakantie en plannen maakt…
16 augustus 2021/door Aurélie Veltema

QuiX levert zijn processor aan Duitsland!

QuiX Quantum, de wereldwijde marktleider in kwantum fotonische…
13 augustus 2021/door Aurélie Veltema

Quantum Delta NL lanceert microfonds van twee miljoen Euro voor quantum startups

Van links naar rechts: Ton van ’t Noordende (Investor in Residence,…
13 augustus 2021/door Aurélie Veltema

QuiX’ fotonische processor is gepubliceerd!

22 juli 2021 – QuiX Quantum heeft vandaag de grootste universele…
22 juli 2021/door Aurélie Veltema